-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Rrz+kfxS+gcRLPCM2MX0eGreJLmneeLln1AdyvVpXqAuFZXzzJxy0DDk6AsMrL7I n61b4lCAaucy2Oc0W1aTxA== 0001269961-05-000005.txt : 20050719 0001269961-05-000005.hdr.sgml : 20050719 20050719165632 ACCESSION NUMBER: 0001269961-05-000005 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20050715 FILED AS OF DATE: 20050719 DATE AS OF CHANGE: 20050719 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NPS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000890465 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 870439579 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 420 CHIPETA WAY STE 240 CITY: SALT LAKE CITY STATE: UT ZIP: 84108-1256 BUSINESS PHONE: 8015834939 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RAUCH ALAN MARK CENTRAL INDEX KEY: 0001269961 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23272 FILM NUMBER: 05962072 BUSINESS ADDRESS: STREET 1: C/O NPS PHARMACEUTICALS STREET 2: 420 CHIPETA WAY CITY: SALT LAKE CITY STATE: UT ZIP: 84108 BUSINESS PHONE: 8015834939 4 1 edgar.xml PRIMARY DOCUMENT X0202 4 2005-07-15 0000890465 NPS PHARMACEUTICALS INC NPSP 0001269961 RAUCH ALAN MARK 383 COLOROW DRIVE SALT LAKE CITY UT 84108 0 1 0 0 VP, Chief Medical Officer Stock Option 11.71 2005-07-15 2005-07-15 4 A 0 8275 0 A 2006-07-15 2015-07-15 Common Stock 8275 8275 D Stock option granted under the 1998 Stock Option Plan. The option becomes exercisable based on the following four-year vesting schedule: 28% on the first anniversary of the grant and 2% each month thereafter. Kevin J. Ontiveros 2005-07-19 -----END PRIVACY-ENHANCED MESSAGE-----